To include your compound in the COVID-19 Resource Center, submit it here.

Teva falls on 3Q results, lowers guidance

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA) plummeted $2.79 (20%)

Read the full 104 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE